Suppr超能文献

Summaries for patients. The cost-effectiveness of full Medicare coverage of angiotensin-converting enzyme inhibitors for patients with diabetes.

出版信息

Ann Intern Med. 2005 Jul 19;143(2):I21. doi: 10.7326/0003-4819-143-2-200507190-00002.

Abstract
摘要

相似文献

2
Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes.
Ann Intern Med. 2005 Jul 19;143(2):89-99. doi: 10.7326/0003-4819-143-2-200507190-00007.
3
Medicare coverage of angiotensin-converting enzyme inhibitors.
Ann Intern Med. 2005 Dec 20;143(12):918; author reply 918. doi: 10.7326/0003-4819-143-12-200512200-00017.
4
The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors.
Ann Intern Med. 1999 Nov 2;131(9):660-7. doi: 10.7326/0003-4819-131-9-199911020-00005.
6
Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.
Scott Med J. 1997 Aug;42(4):99-104. doi: 10.1177/003693309704200401.
7
HOPE for all people with diabetes? Heart Outcomes Prevention Evaluation.
Diabet Med. 2000 Sep;17 Suppl 2:9-10. doi: 10.1046/j.1464-5491.2000.00361-5.x.
9
The emerging role of ACE inhibitors in diabetes: from theory to therapeutic management.
J Diabetes Complications. 1996 May-Jun;10(3):129-32. doi: 10.1016/1056-8727(96)00034-7.
10
The use of ACE inhibitors on diabetic patients without renal disease.
Curr Diab Rep. 2002 Feb;2(1):21-5. doi: 10.1007/s11892-002-0053-y.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验